🚀 🕵♂️ Our Inaugural Open Payments Report is finally here! 🕵♂️ 🚀 We invite you to read the Wall Street Journal's exclusive report coverage: https://lnkd.in/eJmX5-wF In this report, we delve into specific examples and critical questions about industry influence today. We demonstrate how regulators, institutions, and others can use this information to promote transparency and ethical practices in healthcare. Our goal is to provide valuable insights for patients, compliance and legal professionals, policymakers, healthcare providers, and researchers. By identifying and managing conflicts of interest, we aim to help mitigate rising costs and ensure better healthcare outcomes. Download the report now and join us in driving forward transparency and trust in healthcare. https://lnkd.in/eq4EbZzt Feel free to reach out or book a meeting with our team if you have any questions or need further insights. #Conflixis #OpenPayments #HealthcareCompliance #ConflictsOfInterest #HealthcareTransparency #EthicalHealthcare #SupplyChainRisk #ThirdPartyRisk
Conflixis
Technology, Information and Internet
New York, New York 1,807 followers
Discover conflicts of interest and outside influence in your organization.
About us
The Conflixis risk engine unlocks the power of external data and internal information to promote trust and transparency at large organizations.
- Website
-
Www.Conflixis.com
External link for Conflixis
- Industry
- Technology, Information and Internet
- Company size
- 2-10 employees
- Headquarters
- New York, New York
- Type
- Privately Held
- Founded
- 2022
- Specialties
- Risk Discovery, Conflicts, Regulatory Risk, and Reputational Risk
Locations
-
Primary
Get directions
New York, New York, US
Employees at Conflixis
Updates
-
We're #hiring a new Business Development Representative in Dallas, Texas. Apply today or share this post with your network.
-
We're #hiring a new Healthcare Conflict Data Scientist in Dallas, Texas. Apply today or share this post with your network.
-
We're #hiring a new Cloud Infrastructure & Security Engineer in Dallas, Texas. Apply today or share this post with your network.
-
We're #hiring a new Conflict Data Analyst in Dallas, Texas. Apply today or share this post with your network.
-
We did a podcast! Check it out!
📻 📢 We did a podcast! Hear how conflicts impact healthcare organizations from the peerless Robert Wade. In this podcast we go deep on The Open Payments Report and how to understand the very real impact of conflicts inside a healthcare organization. https://lnkd.in/e-sZa6-w Have a listen! #StarkIntegrity #AKS #StarkLaw #FMV #CommercialReasonableness #CaptainIntegrity #NelsonMullins #FCA #OpenPayments #Conflixis
Stark Integrity: Open Payments: A Conversation with Aaron Narva, CEO of Conflixis, Regarding Compliance Findings and Nature of Reported Payments on Apple Podcasts
podcasts.apple.com
-
🔍 Continuing our spotlight on Research Integrity! 🔍 Researchers were paid $67 million to learn about drug and device company products--while doing research funded by that company. Of the $260 million drug and device companies paid to researchers in 2023, $67 million was for speaking and attendance at events that are not for continuing education. Learning about new products and technologies is critical—but when the integrity of research is at stake, more scrutiny is justified. If you work at a research institution and are curious about how your researchers are interacting with industry, get in touch. We will identify your risky relationships—for free. Book a demo with us: https://lnkd.in/eKT5R_Rf Download the 2024 Open Payments report: https://lnkd.in/eq4EbZzt #ResearchIntegrity #ConflictOfInterest #ScienceTransparency #Conflixis #HCCA #AAMC #COI
The O.P. Report — Conflixis
conflixis.com
-
For the next two weeks, Conflixis will be doing spotlight posts on Research Integrity 🔍 Our 2024 Open Payments Report identified numerous researchers who received promotional, consulting, or royalty payments from entities that were funding research they were undertaking in the same twelve-month period. In 2023 alone, researchers received $260 million in non-research-related payments from funders also financing their studies. 💰 Since 2016, this figure totals $2.3 billion. 💰 Despite stringent policies at academic research centers, researchers' financial relationships with funders might compromise research integrity. It's crucial to address these conflicts of interest to ensure unbiased scientific findings and maintain public trust in research. Download your copy of the Open Payments Report here: https://lnkd.in/eq4EbZzt #ResearchIntegrity #ConflictOfInterest #ScienceTransparency
-
-
Latest study from Dr. Aaron Mitchell. Keep it up!!
🚑 💰 📢 Side hustle: Physician influencers are promoting products on X - but many are not disclosing that they are paid to do so. A recent review of 28 U.S. physicians who endorsed drugs or medical devices on X (formerly Twitter) found that they earned nearly $1.5 million from the companies behind these products. 🚀💰 📈🔍 Twenty-six (26) received payments from the endorsed product's manufacturer, and eight failed to disclose speaking or consulting engagements with those manufacturers, giving the appearance of offering an unbiased perspective on a device or drug. As social media overtakes traditional marketing, manufacturers are leveraging the trusted voice of physicians spread their message. 💊 🚦 But what does it mean for hospitals, practice groups and insurers? Significant reputational and regulatory issues: a payment to a physician in exchange for a medical decision is a kickback, disclosed or not--and unnecessary medical procedures and prescriptions cost the insurance industry billions each year. Dive deeper into how Conflixis can help your organization manage conflicts of interest and enhance transparency. Visit us at conflixis.com. #Healthcare #Transparency #SocialMedia #Marketing #Conflixis #ConflictsOfInterest #Innovation #RiskManagement #FTC #tprm #
-
-
Coming soon! The Conflixis Open Payments Report. Stay tuned.
☝ 📢 Its coming in July! Conflixis Announces the very first Open Payments Report 💸 🚑 Ever wonder exactly how pharma companies promote drugs and interact with physicians? Curious now these interactions changed over time? Want to know more about key drugs or devices? Maybe you thought this whole thing was ancient history. Well, we want to show you. Once a year we get the chance to take a data driven look at how health care providers interact with industry thanks to the Open Payments data set. This year Conflixis is going to go deep and share these insights more broadly. We will delve into specific examples and critical questions about how industry influence looks today--and also demonstrate how regulators, institutions and others can use this information. Our goal is to provide valuable insights for patients, compliance and legal professionals, policymakers, healthcare providers, and researchers. Stay tuned for more updates as we approach the release date. Questions? Feel free to reach out or book a meeting with our team. #Conflixis #OpenPayments #HealthcareCompliance #ConflictsOfInterest #HealthcareTransparency #EthicalHealthcare #supplychainrisk #thirdpartyrisk
-